HanSO, GheorghiuD, LiS, et al.Minimum effective dose to achieve biochemical correction with adeno-associated virus vector-mediated gene therapy in mice with Pompe disease. Hum Gen ther, 2022; 33:492–498.
2.
HordeauxJ, JeffreyBA, JianJ, et al.Efficacy and safety of a Krabbe disease gene therapy. Hum Gene Ther, 2022; 33:499–517.
3.
SenterR, BoyceR, RepicM, et al.Efficacy and safety of FX201, a novel intra-articular IL-1Ra gene therapy for osteoarthritis treatment, in a rat model. Hum Gene Ther, 2022; 33:541–549.
4.
SeolD, ChoeHH, ZhengH, et al.Intra-articular adeno-associated virus-mediated proteoglycan 4 gene therapy for preventing posttraumatic osteoarthritis. Hum Gene Ther, 2022; 33:529–540.
